title: Reciprocity in microbiome and immune system interactions and its implications in disease and health.
abstract: Adaptation of the whole microbial normal flora residing in a host to its natural habitat over an evolutionary peroid has resulted in peaceful coexistence with mutual benefits for both microbiota and host in steady state. This symbiotic relationship between host and microbiota has a significant impact on shaping the immune response in the host to achieve an immune tolerance to microbiota but retaining the ability to respond to invading pathogens. Perturbation of this balance by manipulation of microbial communities in the host can lead to immune dysregulation and susceptibility to diseases. By studying the host in the absence of microbiota or with alteration of microbiota the complexity of microbial impact on the immune system can be resolved. Conversely, the study of microbiota in the absence of immune system factors can show how the immune system contributes to preservation of the host-microbiota balance. The absence of molecules involved in innate or adaptive immunity in knockout models can perturb the balance between host and microbiota further adding to more immune dysregulation. A better understanding of Microbiome-immune system interaction provides a new opportunity to identify biomarkers and drug targets. This will allow the development of new therapeutic agents for modulating the immune system to improve health with little or no toxicity. The study of interplay between host and microbiota has a promising role in the design of therapeutic interventions for immunopathological diseases arising from imbalanced host and microbiota interactions.
authors.forename: Enayat
authors.initials: E
authors.lastname: Nikoopour
authors.affiliation: Department of Microbiology and Immunology, University of Western Ontario, London, Ontario N6A 5C1, Canada. bsingh@uwo.ca.
authors.forename: Bhagirath
authors.initials: B
authors.lastname: Singh
mesh_terms: D000818:Animals; D003141:Communicable Diseases / Q000276:immunology / Q000382:microbiology / Q000628:therapy; D004198:Disease Susceptibility; D006304:Health Status; D054884:Host-Pathogen Interactions; D006801:Humans; D007107:Immune System / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D007154:Immune System Diseases / Q000276:immunology / Q000382:microbiology / Q000628:therapy; D007111:Immunity, Cellular; D056724:Immunity, Humoral; D007155:Immunologic Factors / Q000627:therapeutic use; D064307:Microbiota / Q000187:drug effects / Q000276:immunology*; D019936:Probiotics / Q000627:therapeutic use; D011971:Receptors, Immunologic / Q000378:metabolism; D015398:Signal Transduction; D058504:Th17 Cells / Q000276:immunology / Q000382:microbiology
chemical_list: D007155:Immunologic Factors; D011971:Receptors, Immunologic